SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (102)10/20/1999 4:09:00 AM
From: Cheryl Galt  Read Replies (1) of 362
 
Pasting the press release:
biz.yahoo.com
.

Titan Pharmaceuticals, Inc. Calls for Redemption of Its Class A Warrants

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Oct. 19, 1999--Titan Pharmaceuticals, Inc. (AMEX: TTP, TTP:WS) today announced that it has called for redemption of its outstanding class A warrants, at a price of $.05 per warrant.

Each class A warrant is exercisable prior to 5:00 p.m. (Eastern Standard Time), on November 19, 1999, for one share of Titan's Common Stock at an exercise price of $6.02.

After 5:00 p.m. on that date, the class A warrants will no longer be exercisable, and holders will have the right to receive only the redemption price.

The Company has retained Deutsche Banc Alex. Brown as its financial advisor in connection with redemption of the class A warrants.

Questions and requests for assistance in connection with the warrant redemption should be directed to the Company's information agent, D. F. King & Co., Inc. at (212) 269-5550, Attention: Thomas A. Long.

--------------------------------------------------------------------------------
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext